DASA3 Relative Valuation - Diagnosticos da America SA

Watchlist Manager

Watchlist

Price: 4.29 BRL -2.72% Market Closed

Market Cap: R$5.4B

Relative Value

The Relative Value of one DASA3 stock under the Base Case scenario is 10.04 BRL. Compared to the current market price of 4.29 BRL, Diagnosticos da America SA is Undervalued by 57%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

DASA3 Relative Value

Base Case

Undervaluation 57%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
BR	D	Diagnosticos da America SA BOVESPA:DASA3	5.4B BRL	0.4	-4.3	4.5	9
US		CVS Health Corp NYSE:CVS	95.7B USD	0.2	204	13.6	13.6
US	C	Cigna Group XMUN:CGN	61.7B EUR	0.3	11.8	7.6	9.7
US		Cigna Corp NYSE:CI	72.6B USD	0.3	11.8	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	27.9B EUR	1.2	24.2	10.6	16.1
DE		Fresenius Medical Care AG XMUN:FME	23.3B EUR	1.2	32.3	10.2	21.9
US		Laboratory Corporation of America Holdings NYSE:LH	23B USD	1.7	26.9	14.4	20.2
US		Quest Diagnostics Inc NYSE:DGX	20.9B USD	2	22.1	12	16.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.4B EUR	0.6	16	6.4	13.6
US		Guardant Health Inc NASDAQ:GH	12.9B USD	14.7	-33.3	-35.1	-31.8
US		DaVita Inc NYSE:DVA	10.3B USD	0.8	13.1	7.4	10.1

				Revenue Growth	P/S to Growth
BR	D	Diagnosticos da America SA BOVESPA:DASA3	Average P/S: 2.1 0.4	-1%	N/A
US		CVS Health Corp NYSE:CVS	0.2	5%	0
US	C	Cigna Group XMUN:CGN	0.3	8%	0
US		Cigna Corp NYSE:CI	0.3	8%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.2	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.7	7%	0.2
US		Quest Diagnostics Inc NYSE:DGX	2	7%	0.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	14.7	30%	0.5
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
BR	D	Diagnosticos da America SA BOVESPA:DASA3	Average P/E: 40.2 Negative Multiple: -4.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	204	32%	6.4
US	C	Cigna Group XMUN:CGN	11.8	39%	0.3
US		Cigna Corp NYSE:CI	11.8	39%	0.3
DE		Fresenius SE & Co KGaA XETRA:FRE	24.2	71%	0.3
DE		Fresenius Medical Care AG XMUN:FME	32.3	37%	0.9
US		Laboratory Corporation of America Holdings NYSE:LH	26.9	30%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22.1	14%	1.6
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	16	37%	0.4
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -33.3	N/A	N/A
US		DaVita Inc NYSE:DVA	13.1	4%	3.3

				EBITDA Growth	EV/EBITDA to Growth
BR	D	Diagnosticos da America SA BOVESPA:DASA3	Average EV/EBITDA: 9.6 4.5	8%	0.6
US		CVS Health Corp NYSE:CVS	13.6	25%	0.5
US	C	Cigna Group XMUN:CGN	7.6	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	10.6	14%	0.8
DE		Fresenius Medical Care AG XMUN:FME	10.2	10%	1
US		Laboratory Corporation of America Holdings NYSE:LH	14.4	16%	0.9
US		Quest Diagnostics Inc NYSE:DGX	12	8%	1.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	6.4	10%	0.6
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -35.1	N/A	N/A
US		DaVita Inc NYSE:DVA	7.4	4%	1.9

				EBIT Growth	EV/EBIT to Growth
BR	D	Diagnosticos da America SA BOVESPA:DASA3	Average EV/EBIT: 14.5 9	17%	0.5
US		CVS Health Corp NYSE:CVS	13.6	19%	0.7
US	C	Cigna Group XMUN:CGN	9.7	5%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	16.1	20%	0.8
DE		Fresenius Medical Care AG XMUN:FME	21.9	25%	0.9
US		Laboratory Corporation of America Holdings NYSE:LH	20.2	27%	0.7
US		Quest Diagnostics Inc NYSE:DGX	16.3	11%	1.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	13.6	25%	0.5
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -31.8	N/A	N/A
US		DaVita Inc NYSE:DVA	10.1	4%	2.5

Diagnosticos da America SA
BOVESPA:DASA3

Relative Value

Valuation Multiples

Multiples Across Competitors

DASA3 Competitors Multiples
Diagnosticos da America SA Competitors

See Also

Company

Help

Tools

Stocks

Diagnosticos da America SA BOVESPA:DASA3

Relative Value

Valuation Multiples

Multiples Across Competitors

DASA3 Competitors Multiples Diagnosticos da America SA Competitors

See Also

Company

Help

Tools

Stocks

Diagnosticos da America SA
BOVESPA:DASA3

DASA3 Competitors Multiples
Diagnosticos da America SA Competitors